Home / STEK : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does STEK make money? Does STEK have pricing power? What's the Earnings Whisper? Will STEK profit more as the business scales? What is STEK's management track record? Is STEK's current price justified?

Stemtech Corporation

$0 -$0.00 (-88.89%)

OTC · 14 Sep 2026 14:27 UTC

Previous Close

Day Range

$0$0

Year Range

$0$0.02

Market Cap

216.93K

AVG Volume

29.4M

Trailing/Forward PE

-0.01/-

PEG ratio

-0

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (USD)

STEK Revenue (USD) by year
Period	Revenue (USD)
2025	2.88M
2024	5.05M
2023	4.92M
2022	4.56M
2021	4.32M
2020	5.16M

Net Income (USD)

STEK Net Income (USD) by year
Period	Net Income (USD)
2025	-4.04M
2024	-3.77M
2023	-5.43M
2022	-8.9M
2021	-7.08M
2020	-848.82K

Operating Income (USD)

STEK Operating Income (USD) by year
Period	Operating Income (USD)
2025	-2.71M
2024	-2.39M
2023	-4.22M
2022	-5.02M
2021	-3.21M
2020	-1.36M

EBITDA (USD)

STEK EBITDA (USD) by year
Period	EBITDA (USD)
2025	-2.46M
2024	-1.78M
2023	48.85K
2022	-3.99M
2021	1.74M
2020	-782.29K

Cash Flows (USD)

STEK Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-484.81K
2024	-601.2K
2023	-2.02M
2022	-1.22M
2021	-1.91M
2020	-385.19K

EPS (USD)

STEK EPS (USD) by year
Period	EPS (USD)
2025	-0.02
2024	-0.04
2023	-0.07
2022	-0.21
2021	-0.33
2020	-0.04

Expenses (USD)

STEK Expenses (USD) by year
Period	Expenses (USD)
2025	4.58M
2024	5.33M
2023	6.96M
2022	8.11M
2021	6.51M
2020	5.67M

Cash & Debt (USD)

STEK Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	238.25K
2024	255.3K
2023	114.17K
2022	132.49K
2021	828.21K
2020	133.06K
2018	6.67K
2017	8.6K

Debt ratios

STEK Debt ratios by year
Period	Debt ratios
2025	-0.26
2024	-0.89
2023	-1.2

Margins

STEK Margins by year
Period	Margins
2025	80.29%
2024	73.75%
2023	79.65%
2022	74.47%
2021	76.32%
2020	83.22%

Return on Capital

STEK Return on Capital by year
Period	Return on Capital
2025	52.44%
2024	72.12%
2023	195.42%
2022	280.48%
2021	176.71%
2020	-66.94%

Shares Outstanding

STEK Shares Outstanding by year
Period	Shares Outstanding
2025	169.82M
2024	118.7M
2023	104.99M
2022	46.01M
2021	35.31M
2020	34.93M

Book Value Per Share (USD)

STEK Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	-0.05
2024	-0.04
2023	-0.03
2022	-0.07
2021	-0.11
2020	0.04

Total Assets (USD)

STEK Total Assets (USD) by year
Period	Total Assets (USD)
2025	3.15M
2024	3.78M
2023	3.68M
2022	4.27M
2021	5.72M
2020	5.01M
2018	12.06K
2017	17.09K

PE Ratio

STEK PE Ratio by year
Period	PE Ratio
Nov 23	0.22
Nov 23	0.22
Nov 23	0.21
Nov 23	0.21
Oct 23	0.21
Oct 23	0.23
Oct 23	0.24
Oct 23	0.25
Sep 23	0.24
Sep 23	0.23
Sep 23	0.27
Sep 23	0.27
Sep 23	0.25
Aug 23	0.23

Free Cash Flow Yield

STEK Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-15884.22%
Sep 26	-158.84%
Sep 26	-15884.22%
Aug 26	-158.84%
Aug 26	-158.84%
Aug 26	-158.84%
Aug 26	-246.5%
Jul 26	-246.5%
Jul 26	-246.5%
Jul 26	-246.5%
Jul 26	-246.5%
Jul 26	-246.5%
Jun 26	-246.5%
Jun 26	-1427.44%
Jun 26	-1427.44%
Jun 26	-1427.44%
May 26	-1427.44%
May 26	-10861.12%
May 26	-5430.56%
May 26	-5430.56%
May 26	-3620.37%
Apr 26	-5430.56%
Apr 26	-5430.56%
Apr 26	-4344.45%
Apr 26	-10861.12%
Mar 26	-5430.56%
Mar 26	-5430.56%
Mar 26	-4344.45%
Mar 26	-3620.37%
Feb 26	-3620.37%
Feb 26	-2715.28%
Feb 26	-2715.28%
Feb 26	-2172.22%
Jan 26	-1974.75%
Jan 26	-1810.19%
Jan 26	-1810.19%
Jan 26	-1751.79%
Jan 26	-1206.79%
Dec 25	-1086.11%
Dec 25	-835.47%
Dec 25	-724.07%
Dec 25	-603.4%
Nov 25	-603.4%
Nov 25	-638.89%
Nov 25	-663.06%
Nov 25	-455.86%
Oct 25	-416.78%
Oct 25	-217.72%
Oct 25	-291.75%
Oct 25	-177.9%
Oct 25	-112.21%
Sep 25	-94.11%
Sep 25	-123.62%
Sep 25	-106.32%
Sep 25	-104.2%
Aug 25	-85.31%
Aug 25	-67.22%
Aug 25	-76.29%
Aug 25	-71.62%
Aug 25	-66.74%
Jul 25	-72.95%
Jul 25	-70.94%
Jul 25	-20.57%
Jul 25	-17.17%
Jun 25	-18.2%
Jun 25	-16.92%
Jun 25	-17.59%
Jun 25	-14.51%
May 25	-14.42%
May 25	-16.59%
May 25	-18.74%
May 25	-28.53%
May 25	-25.24%
Apr 25	-23.69%
Apr 25	-23.74%
Apr 25	-22.33%
Apr 25	-20.02%
Mar 25	-16.61%
Mar 25	-16.68%
Mar 25	-14.88%
Mar 25	-15.27%
Feb 25	-14.87%
Feb 25	-14.09%
Feb 25	-14.62%
Feb 25	-14.7%
Jan 25	-13.04%
Jan 25	-13.52%
Jan 25	-12.35%
Jan 25	-15.22%
Jan 25	-11.43%
Dec 24	-12.61%
Dec 24	-12.2%
Dec 24	-12.28%
Dec 24	-11.61%
Nov 24	-11.61%
Nov 24	-10.61%
Nov 24	-9.84%
Nov 24	-10.08%
Nov 24	-8.98%
Oct 24	-6.25%

Price to Sales

STEK Price to Sales by year
Period	Price to Sales
Sep 26	0
Sep 26	0.09
Sep 26	0
Aug 26	0.09
Aug 26	0.09
Aug 26	0.09
Aug 26	0.03
Jul 26	0.03
Jul 26	0.03
Jul 26	0.03
Jul 26	0.03
Jul 26	0.03
Jun 26	0.03
Jun 26	0.01
Jun 26	0.01
Jun 26	0.01
May 26	0.01
May 26	0
May 26	0.01
May 26	0.01
May 26	0.01
Apr 26	0.01
Apr 26	0.01
Apr 26	0.01
Apr 26	0
Mar 26	0.01
Mar 26	0.01
Mar 26	0.01
Mar 26	0.01
Feb 26	0.01
Feb 26	0.02
Feb 26	0.02
Feb 26	0.02
Jan 26	0.02
Jan 26	0.02
Jan 26	0.02
Jan 26	0.02
Jan 26	0.04
Dec 25	0.04
Dec 25	0.05
Dec 25	0.06
Dec 25	0.07
Nov 25	0.07
Nov 25	0.07
Nov 25	0.08
Nov 25	0.12
Oct 25	0.13
Oct 25	0.24
Oct 25	0.18
Oct 25	0.3
Oct 25	0.47
Sep 25	0.56
Sep 25	0.43
Sep 25	0.5
Sep 25	0.51
Aug 25	0.62
Aug 25	0.79
Aug 25	0.67
Aug 25	0.72
Aug 25	0.77
Jul 25	0.7
Jul 25	0.72
Jul 25	0.58
Jul 25	0.69
Jun 25	0.75
Jun 25	0.81
Jun 25	0.78
Jun 25	0.95
May 25	0.95
May 25	0.83
May 25	0.73
May 25	0.48
May 25	0.54
Apr 25	0.58
Apr 25	0.58
Apr 25	0.61
Apr 25	0.69
Mar 25	0.83
Mar 25	0.82
Mar 25	0.92
Mar 25	0.9
Feb 25	0.92
Feb 25	0.97
Feb 25	0.94
Feb 25	0.93
Jan 25	1.05
Jan 25	1.02
Jan 25	1.11
Jan 25	0.9
Jan 25	1.2
Dec 24	1.09
Dec 24	1.12
Dec 24	1.12
Dec 24	1.18
Nov 24	1.18
Nov 24	1.29
Nov 24	0.54
Nov 24	0.52
Nov 24	0.59
Oct 24	0.84

EV/EBITDA

STEK EV/EBITDA by year
Period	EV/EBITDA
Jul 24	196.56
Jul 24	4.19
Jun 24	4.39
Jun 24	4.18
Jun 24	4.08
Jun 24	3.71
May 24	3.92
May 24	3.87
May 24	4.07
May 24	4.4
May 24	4.45
Apr 24	4.63
Apr 24	4.71
Apr 24	5.26
Apr 24	5.01
Mar 24	5.27
Mar 24	6.47
Mar 24	3.99
Mar 24	3.42
Mar 24	2.92
Feb 24	2.96
Feb 24	2.89
Feb 24	2.97
Feb 24	2.99
Jan 24	2.96
Jan 24	2.9
Jan 24	2.94
Jan 24	3.01
Dec 23	3.09
Dec 23	3.03
Dec 23	2.96
Dec 23	3.06
Dec 23	2.76
Nov 23	0.25
Nov 23	0.25
Nov 23	0.24
Nov 23	0.24
Oct 23	0.25
Oct 23	0.26
Oct 23	0.26
Oct 23	0.27
Sep 23	0.26
Sep 23	0.26
Sep 23	0.28
Sep 23	0.28
Sep 23	0.27
Aug 23	0.26
Aug 22	165.5
Aug 22	183.44
Aug 22	255.22
Jul 22	192.12
Jul 22	259.71
Jul 22	203.48
Jul 22	155.33
Jul 22	150.55
Jun 22	150.55
Jun 22	150.55
Jun 22	90.73
Jun 22	90.73
May 22	90.73
May 22	90.73
May 22	57.23
May 22	57.23
Apr 22	60.89
Apr 22	63.32
Apr 22	63.32
Apr 22	52.15
Apr 22	52.15
Mar 22	49.17
Mar 22	39.49
Mar 22	39.29
Mar 22	58.46
Feb 22	48.18
Feb 22	42.85
Feb 22	39.69
Feb 22	38.9
Jan 22	38.9
Jan 22	38.9
Jan 22	39.1
Jan 22	38.9
Dec 21	46.21
Dec 21	68.53
Dec 21	25.27
Dec 21	58.06
Dec 21	57.87
Nov 21	58.66

No video analysis for this stock yet. Request one from our team.

News: STEK

accessnewswire.com · 20 Aug 2026

Stemtech Corporation Appoints Alejandro Carrillio President, Latin Markets

LIVE LONGER - LIVE BETTER - LIVE YOUNGER NAPLES, FL / ACCESS Newswire / August 20, 2026 / Stemtech Corporation (OTCID:STEK), the global leader and pioneer in stem cell nutrition (stemceutical™) products, today announced the appointment of Alejandro Carrillo to President, Latin Markets. Carrillo most recently served as Vice President of Global Sales, and his appointment reflects the company's continued investment in the leadership driving its strongest-performing market segment.

accessnewswire.com · 1 Jul 2026

Stemtech Corporation Declares July 2026 "Cellular Health Awareness Month"

Spotlighting Two Decades of Natural Regenerative Support, Anti-Aging and Longevity Science, AI-Recognized Pioneer-Leader in Stem Cell Nutrition Marks 20 Years of All-Natural, Plant-Based Stemceuticals™ With a Company-Wide Education Initiative NAPLES, FL / ACCESS Newswire / July 1, 2026 / Stemtech Corporation (OTCID:STEK), the global pioneer and leader in stem cell nutrition, today announced that it has designated July 2026 as Cellular Health Awareness Month, a company-wide initiative dedicated to educating consumers, Independent Business Partners (IBPs), and the wellness community on the science of natural regenerative support, healthy aging, and longevity. "Live Longer - Live Better - Live Younger" For two decades, Stemtech has championed an all-natural, plant-based approach to cellular wellness - long before "longevity" became a mainstream conversation.

accessnewswire.com · 23 Jun 2026

Stemtech Corporation Issues 2025 Year-In-Review Letter Highlighting Corporate Strength, Global Expansion and Accelerating Market Opportunities

LIVE LONGER - LIVE BETTER - LIVE YOUNGER Newly Secured Inventory Funding and Global Expansion Position the Company for Scalable Growth Amid Accelerating Demand NAPLES, FL / ACCESS Newswire / June 23, 2026 / Stemtech Corporation (OTCID:STEK), a The Pioneer and global leader in stem cell nutrition and plant-based wellness solutions, today issued a joint letter to shareholders from Chairman and Chief Executive Officer Charles S. Arnold and President and Chief Operating Officer John W.